Literature DB >> 33255892

Adenovirus-Extracellular Protein Interactions and Their Impact on Innate Immune Responses by Human Mononuclear Phagocytes.

Coraline Chéneau1, Eric J Kremer1.   

Abstract

The aim of this review is to highlight how, in a syngeneic system, human mononuclear phagocytes respond to environments containing human adenovirus (HAdV) and soluble extracellular proteins that influence their innate immune response. Soluble extracellular proteins, including immunoglobulins, blood clotting factors, proteins of the complement system, and/or antimicrobial peptides (AMPs) can exert direct effects by binding to a virus capsid that modifies interactions with pattern recognition receptors and downstream signaling. In addition, the presence, generation, or secretion of extracellular proteins can indirectly influence the response to HAdVs via the activation and recruitment of cells at the site of infection.

Entities:  

Keywords:  adenovirus; alarmin; antibody; antimicrobial peptide; coagulation factor; complement; dendritic cell; host defense peptide; innate immunity

Mesh:

Substances:

Year:  2020        PMID: 33255892      PMCID: PMC7760109          DOI: 10.3390/v12121351

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  128 in total

Review 1.  Immune adherence revisited: novel players in an old game.

Authors:  Christoph Hess; Jürg A Schifferli
Journal:  News Physiol Sci       Date:  2003-06

Review 2.  AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense.

Authors:  Yuping Lai; Richard L Gallo
Journal:  Trends Immunol       Date:  2009-02-13       Impact factor: 16.687

Review 3.  Adenoviruses across the animal kingdom: a walk in the zoo.

Authors:  Balázs Harrach; Zoltán L Tarján; Mária Benkő
Journal:  FEBS Lett       Date:  2019-12-09       Impact factor: 4.124

Review 4.  Achieving systemic delivery of oncolytic viruses.

Authors:  Claudia Hill; Robert Carlisle
Journal:  Expert Opin Drug Deliv       Date:  2019-05-30       Impact factor: 6.648

5.  Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells.

Authors:  D Yang; Q Chen; O Chertov; J J Oppenheim
Journal:  J Leukoc Biol       Date:  2000-07       Impact factor: 4.962

Review 6.  Structure of human adenovirus.

Authors:  Glen R Nemerow; Phoebe L Stewart; Vijay S Reddy
Journal:  Curr Opin Virol       Date:  2012-01-18       Impact factor: 7.090

7.  Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases development.

Authors:  S Lavilla-Alonso; M M T Bauer; U Abo-Ramadan; A Ristimäki; J Halavaara; R A Desmond; D Wang; S Escutenaire; L Ahtiainen; K Saksela; T Tatlisumak; A Hemminki; S Pesonen
Journal:  Cancer Gene Ther       Date:  2011-11-18       Impact factor: 5.987

Review 8.  The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts.

Authors:  Nicolau B da Cunha; Nicole B Cobacho; Juliane F C Viana; Loiane A Lima; Kamila B O Sampaio; Stephan S M Dohms; Arthur C R Ferreira; César de la Fuente-Núñez; Fabrício F Costa; Octávio L Franco; Simoni C Dias
Journal:  Drug Discov Today       Date:  2016-11-23       Impact factor: 7.851

9.  Defensins Potentiate a Neutralizing Antibody Response to Enteric Viral Infection.

Authors:  Anshu P Gounder; Nicolle D Myers; Piper M Treuting; Beth A Bromme; Sarah S Wilson; Mayim E Wiens; Wuyuan Lu; André J Ouellette; Katherine R Spindler; William C Parks; Jason G Smith
Journal:  PLoS Pathog       Date:  2016-03-02       Impact factor: 6.823

10.  Intestinal Adenovirus Shedding Before Allogeneic Stem Cell Transplantation Is a Risk Factor for Invasive Infection Post-transplant.

Authors:  Karin Kosulin; Bettina Berkowitsch; Susanne Matthes; Herbert Pichler; Anita Lawitschka; Ulrike Pötschger; Gerhard Fritsch; Thomas Lion
Journal:  EBioMedicine       Date:  2018-01-09       Impact factor: 8.143

View more
  7 in total

Review 1.  Is complement the culprit behind COVID-19 vaccine-related adverse reactions?

Authors:  Dimitrios C Mastellos; Panagiotis Skendros; John D Lambris
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

Review 2.  Human Adenovirus Species D Interactions with Corneal Stromal Cells.

Authors:  Jaya Rajaiya; Amrita Saha; Xiaohong Zhou; James Chodosh
Journal:  Viruses       Date:  2021-12-14       Impact factor: 5.048

Review 3.  Adenoviral vector-based platforms for developing effective vaccines to combat respiratory viral infections.

Authors:  Ahmed Elkashif; Marwa Alhashimi; Ekramy E Sayedahmed; Suryaprakash Sambhara; Suresh K Mittal
Journal:  Clin Transl Immunology       Date:  2021-10-12

4.  Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.

Authors:  Andreas Greinacher; Kathleen Selleng; Raghavendra Palankar; Jan Wesche; Stefan Handtke; Martina Wolff; Konstanze Aurich; Michael Lalk; Karen Methling; Uwe Völker; Christian Hentschker; Stephan Michalik; Leif Steil; Alexander Reder; Linda Schönborn; Martin Beer; Kati Franzke; Andreas Büttner; Boris Fehse; Evi X Stavrou; Chandini Rangaswamy; Reiner K Mailer; Hanna Englert; Maike Frye; Thomas Thiele; Stefan Kochanek; Lea Krutzke; Florian Siegerist; Nicole Endlich; Theodore E Warkentin; Thomas Renné
Journal:  Blood       Date:  2021-12-02       Impact factor: 25.476

Review 5.  Adenovirus-based vaccines-a platform for pandemic preparedness against emerging viral pathogens.

Authors:  Lynda Coughlan; Eric J Kremer; Dmitry M Shayakhmetov
Journal:  Mol Ther       Date:  2022-01-31       Impact factor: 12.910

6.  Versatile nanorobot hand biosensor for specific capture and ultrasensitive quantification of viral nanoparticles.

Authors:  Rui Li; Ya Zhao; Hongli Fan; Mingqian Chen; Wenjun Hu; Qiang Zhang; Meilin Jin; Gang L Liu; Liping Huang
Journal:  Mater Today Bio       Date:  2022-09-28

7.  Special Issue "Adenovirus Pathogenesis".

Authors:  Niklas Arnberg; Annasara Lenman
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.